Compounds > 5,7-dihydroxytryptamine
Page last updated: 2024-08-23

5,7-dihydroxytryptamine and Acute Disease

5,7-dihydroxytryptamine has been researched along with Acute Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amado, D; Cavalheiro, EA; de A Carvalho, R; de Castro-Neto, EF; Lima, E; Naffah-Mazzacoratti, Mda G; Scorza, FA; Trindade-Filho, EM1
Coimbra, NC; Guimarães, FS; Joca, SR; Netto, SM; Silveira, R1

Other Studies

2 other study(ies) available for 5,7-dihydroxytryptamine and Acute Disease

ArticleYear
Serotonin depletion effects on the pilocarpine model of epilepsy.
    Epilepsy research, 2008, Volume: 82, Issue:2-3

    Topics: 5,7-Dihydroxytryptamine; Acute Disease; Animals; Behavior, Animal; Chronic Disease; Disease Models, Animal; Disease Susceptibility; Electroencephalography; Epilepsies, Partial; Hippocampus; Male; Muscarinic Agonists; Pilocarpine; Raphe Nuclei; Rats; Rats, Wistar; Recurrence; Serotonin; Serotonin Antagonists; Status Epilepticus

2008
Anxiogenic effect of median raphe nucleus lesion in stressed rats.
    Progress in neuro-psychopharmacology & biological psychiatry, 2002, Volume: 26, Issue:6

    Topics: 5,7-Dihydroxytryptamine; Acute Disease; Animals; Anxiety; Biogenic Monoamines; Chromatography, High Pressure Liquid; Chronic Disease; Hippocampus; Hydroxyindoleacetic Acid; Male; Norepinephrine; Raphe Nuclei; Rats; Rats, Wistar; Restraint, Physical; Serotonin; Serotonin Agents; Stress, Psychological

2002